Peijia Medical Obtained Exclusive License for JenaValve's Trilogy TAVR System for Treating AR in the Greater China Region

SUZHOU, China, Jan. 19, 2022 /PRNewswire/ -- Peijia Medical Limited (HKEX: 9996) is pleased to announce its strategic investment and exclusive in-...

Related Keywords

Germany ,United States ,Hong Kong ,Munich ,Bayern ,Yi Zhang ,Shaanxi ,China ,Suzhou ,Jiangsu ,Peijia ,Henan ,California ,Irvine ,John Kilcoyne ,Gimv Euronext ,Bain Capital Life Sciences ,Drug Administration ,Peijia Medical Limited ,Jenavalve Technology Inc ,Peijia Medical ,Prnewswire Peijia Medical Limited ,Hong Kong Stock Exchange ,Valiance Life Sciences ,Medical Limited ,Jenavalve Technology ,Greater China ,Valve Technology ,Breakthrough Device Designation ,Valve System ,Chief Executive ,Jiangsu Province ,Cormorant Asset Management ,Andera Partners ,Legend Capital ,Neomed Management ,